Eluned Morgan MS, Minister for Health and Social Services
UK clinical trials have played a critical role in the development of effective vaccines against COVID-19 and I am extremely grateful to the many people from Wales who took part in a vaccine trial. Just under 1,400 people in Wales selflessly stepped up when we needed them. It is a truly remarkable act of generosity and kindness to their fellow human beings.
Trial participants were rightly promised they would not be disadvantaged for taking part in approved COVID-19 vaccine trials in the UK. However, I know some trial participants have had difficulty accessing a booster vaccination or COVID international Travel Pass. This is because not all trial participants received a vaccine approved by the Medicines and Healthcare Regulatory Authority (MHRA).
Today, the Chief Medical Officer for Wales has written to trial investigators and NHS medical directors across Wales to set out the process for addressing this issue as quickly as possible. From tomorrow, trial participants will start to receive letters explaining how, if they meet the eligibility criteria, they will be offered their booster, or if they require one, how to get a further primary course of vaccine to enable them to get a COVID Travel Pass. This is in line with principles endorsed by the Joint Committee on Vaccination and Immunisation (JCVI) for trial participants.
I am determined to resolve this issue for everyone affected in Wales in recognition of their contribution that has benefited us all.